Tehran / Perth / Rome / Sao Paulo / Bogota / Prague / Teheran / São Paulo / Florence / /
Company
The Associated Press / /
Continent
America / Asia / North America / Europe / /
Country
Uruguay / Myanmar / Italy / Cambodia / Laos / Iran / Peru / Poland / Thailand / Colombia / United States / Brazil / St. Lucia / Australia / Philippines / Argentina / Bolivia / Spain / Czech Republic / /
Event
FDA Phase / /
Facility
Federal University of Sao Paulo / Transnational Institute / /
IndustryTerm
pharmaceutical drug / drugs/equipment / retail smart shops / user networks / drug services / drug control systems / HCV prevention / chemical aspects / moderation management / food / target / harm reduction tools / licit pharmaceutical drug / appropriate services / treatment for cocaine and paco withdrawal syndrome / drug addiction services / media campaign / chemical composition / chemical properties / online self-management / mainstream health services / internet surfers / law enforcement interventions / harm reduction services / low threshold services / Law enforcement / Drug treatment services / penal law / /
MusicAlbum
Asia / Oceania / /
NaturalFeature
Mekong river / /
Organization
Open Society Foundation / Drug Checking Service / University of Sao Paulo / Polish Government / National Park Service / Czech police / Transnational Institute / European Union / Health Service / /
Person
Eliseu Labigalini Jr / Lucio Ribeiro Rodrigues / Dartiu Xavier Da Silveira / /
Position
mayor / Matrix Model / and inpatient treatment centers / important driver / king / /
Product
Ritalin tablet / Ritalin / Australia / /
ProgrammingLanguage
EC / /
ProvinceOrState
Western Australia / Tuscany / /
PublishedMedium
The Globe and Mail / Journal of Psychoactive Drugs / /
Region
South East Asia / Oceania / West Australia / East Asia / Latin America / Caribbean / Southeast Asia / Eastern Europe / Western Australia / Golden Triangle / /
Expert Seminar Rome, May 20th 2014 Global Experiences with Harm Reduction for Stimulants and New Psychoactive Substances The Expert Seminar on the Global Experiences with Harm Reduction for Stimulants and New Psychoactiv